102 related articles for article (PubMed ID: 12368959)
1. Histological improvement with lamivudine therapy for de novo hepatitis B occurring in an anti-HBs-positive child after bone marrow transplantation.
Yeung LT; Petric M; Cutz E; Roberts EA
Bone Marrow Transplant; 2002 Oct; 30(7):459-62. PubMed ID: 12368959
[TBL] [Abstract][Full Text] [Related]
2. Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
Hashino S; Nozawa A; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Hige S; Asaka M
Bone Marrow Transplant; 2002 Feb; 29(4):361-3. PubMed ID: 11896435
[TBL] [Abstract][Full Text] [Related]
3. Reverse seroconversion of hepatitis B virus infectious status after allogeneic bone marrow transplantation from a carrier donor.
Fan FS; Tzeng CH; Yeh HM; Chen PM
Bone Marrow Transplant; 1992 Aug; 10(2):189-91. PubMed ID: 1525609
[TBL] [Abstract][Full Text] [Related]
4. Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation.
Picardi M; Selleri C; De Rosa G; Raiola A; Pezzullo L; Rotoli B
Bone Marrow Transplant; 1998 Jun; 21(12):1267-9. PubMed ID: 9674862
[TBL] [Abstract][Full Text] [Related]
5. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.
Kempinska A; Kwak EJ; Angel JB
Clin Infect Dis; 2005 Nov; 41(9):1277-82. PubMed ID: 16206102
[TBL] [Abstract][Full Text] [Related]
7. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
8. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
[TBL] [Abstract][Full Text] [Related]
9. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
Uhm JE; Kim K; Lim TK; Park BB; Park S; Hong YS; Lee SC; Hwang IG; Koh KC; Lee MH; Ahn JS; Kim WS; Jung CW; Kang WK
Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH
Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
[TBL] [Abstract][Full Text] [Related]
11. Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudine.
Hashino S; Takahata M; Nozawa A; Izumiyama K; Chiba K; Suzuki S; Hige S; Asaka M
Bone Marrow Transplant; 2002 Feb; 29(3):269-71. PubMed ID: 11859401
[TBL] [Abstract][Full Text] [Related]
12. Changes in serological markers of hepatitis B virus after renal transplantation.
Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.
Pérez-Grande R; Gutiérrez-Zufiaurre N; Muñoz-Criado S; Blázquez de Castro AM; Vázquez López L; González San Martín F; García Rodríguez JA; Muñoz Bellido JL
Diagn Microbiol Infect Dis; 2009 May; 64(1):80-2. PubMed ID: 19304434
[TBL] [Abstract][Full Text] [Related]
14. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.
Kitano K; Kobayashi H; Hanamura M; Furuta K; Ueno M; Rokuhara A; Tanaka E; Umemura T; Kiyosawa K
Eur J Haematol; 2006 Sep; 77(3):255-8. PubMed ID: 16923112
[TBL] [Abstract][Full Text] [Related]
15. [Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
Sugimoto R; Enjoji M; Kotoh K; Noguchi K; Tsuruta S; Nakamuta M; Nawata H
Fukuoka Igaku Zasshi; 2004 Oct; 95(10):274-9. PubMed ID: 15678886
[TBL] [Abstract][Full Text] [Related]
16. Lamivudine treatment for acute severe hepatitis B: a pilot study.
Schmilovitz-Weiss H; Ben-Ari Z; Sikuler E; Zuckerman E; Sbeit W; Ackerman Z; Safadi R; Lurie Y; Rosner G; Tur-Kaspa R; Reshef R
Liver Int; 2004 Dec; 24(6):547-51. PubMed ID: 15566503
[TBL] [Abstract][Full Text] [Related]
17. Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.
Hsiao LT; Chiou TJ; Liu JH; Chu CJ; Lin YC; Chao TC; Wang WS; Yen CC; Yang MH; Tzeng CH; Chen PM
Biol Blood Marrow Transplant; 2006 Jan; 12(1):84-94. PubMed ID: 16399572
[TBL] [Abstract][Full Text] [Related]
18. Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients?
Orlando R; Tosone G; Tiseo D; Piazza M; Portella G; Ciancia R; Martinelli V; Montante B; Rotoli B
Infection; 2006 Oct; 34(5):282-4. PubMed ID: 17033754
[TBL] [Abstract][Full Text] [Related]
19. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
[TBL] [Abstract][Full Text] [Related]
20. Fatal hepatitis B reactivation after autologous bone marrow transplantation.
Webster A; Brenner MK; Prentice HG; Griffiths PD
Bone Marrow Transplant; 1989 Mar; 4(2):207-8. PubMed ID: 2650792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
